Cite
HARVARD Citation
Abraham, G. et al. (2022). The clinical utility and safety of short‐course immune checkpoint inhibitors in multiple tumours—A real‐world multicentric study from India. International journal of cancer. 150 (6), pp. 1045-1052. [Online].